CIDEX OPA

Mechanism of action

Benzotriazole functions primarily through its ability to inhibit the corrosion of metals by forming a protective layer on the surface of the metal. It acts as a chelating agent that can bind to metal ions, preventing their reactivity. This mechanism helps in stabilizing certain compounds and preventing degradation.

Pharmacodynamics

The pharmacodynamic properties of benzotriazole are not well-characterized in clinical literature. Its primary function relates to its chemical stability and its role as a protective agent in various formulations rather than direct therapeutic effects on biological systems.

Pharmacokinetics

Data regarding the pharmacokinetics of benzotriazole in humans is limited. However, it is known that compounds similar to benzotriazole may undergo metabolism via hydroxylation and conjugation, with elimination primarily occurring through renal pathways. The exact absorption, distribution, metabolism, and excretion characteristics of benzotriazole in humans require further study.

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether benzotriazole is excreted in human milk. Caution should be exercised when administering to a nursing woman.

Storage

Store in a cool, dry place, away from moisture and light. Keep container tightly closed.

Indications

• Acidulant in food and beverages
• Preservative in pharmaceutical formulations
• pH adjuster in various chemical preparations

Dosage

Children: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Adults: Refer to product-specific guidelines for appropriate dosing based on formulation and indication.

Mechanism of action

Citric acid acts by chelating metal ions, which can enhance the solubility of certain compounds and improve their bioavailability. It also contributes to the acidity of the environment, which can influence enzymatic activity and metabolic pathways, particularly in the degradation of citronellol.

Pharmacodynamics

Citric acid exhibits mild pharmacological effects primarily attributed to its role in metabolic processes. It aids in the regulation of pH levels, which can impact enzymatic reactions and biochemical pathways. The acid's chelating properties may help to reduce the toxicity of certain metal ions in biological systems.

Pharmacokinetics

Citric acid is rapidly absorbed after oral administration and is metabolized in the liver. It undergoes conversion to various metabolites in the citric acid cycle, contributing to energy production. The elimination primarily occurs through urine, with minimal accumulation in the body.

Pregnancy

Citric acid is generally regarded as safe during pregnancy when used in food amounts. However, consult a healthcare provider for advice on medicinal use.

Breast-feeding

Citric acid is considered safe during breastfeeding when consumed in food amounts. For medicinal use, consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Preparation of intravenous solutions
• Dilution of medications
• Laboratory experiments
• Cleaning of instruments and equipment

Dosage

Children: Deionised water is used as a solvent or diluent and does not have a specific dosage. Refer to specific guidelines for preparation and administration based on the formulation.

Adults: Deionised water is used as a solvent or diluent and does not have a specific dosage. Refer to specific guidelines for preparation and administration based on the formulation.

Mechanism of action

Deionisation involves the removal of charged particles from water through ion exchange processes. In this process, water passes through a resin that attracts and binds cations and anions, effectively removing them from the water. This results in water that is free of dissolved salts and impurities, making it suitable for various applications where mineral content can interfere with results or processes.

Pharmacodynamics

Deionised water does not have pharmacodynamic effects in the traditional sense, as it is not a drug but rather a form of purified water. Its primary role in clinical applications is to serve as a solvent or diluent in formulations, ensuring that medications or other substances are delivered without interference from ionic contaminants.

Pharmacokinetics

Since deionised water is not a drug, it does not undergo pharmacokinetic processes such as absorption, distribution, metabolism, or excretion. However, when used in medical settings, it is important to ensure that any solutions prepared with deionised water maintain sterility and do not introduce contaminants. The use of deionised water as a solvent allows for optimal solubility of other compounds used in treatments.

Pregnancy

Deionised water is generally considered safe during pregnancy as it is chemically pure and does not contain impurities that could harm the fetus.

Breast-feeding

Deionised water is safe during breastfeeding as it does not contain harmful substances.

Storage

Store in a clean, sealed container to prevent contamination, away from direct sunlight and extreme temperatures.

Formulations

• Deionised water

Indications

• Hypokalemia
• Electrolyte imbalance
• Nutritional supplementation

Dosage

Children: Refer to the BNF for Children for specific dosing recommendations based on the child's age and condition.

Adults: Refer to the BNF for specific dosing recommendations based on the clinical condition being treated.

Mechanism of action

Dipotassium phosphate dissociates in solution to release potassium and phosphate ions. Potassium is essential for numerous physiological functions, including nerve impulse transmission, muscle contraction, and maintenance of normal cellular function. Phosphate plays a critical role in energy production, cellular signaling, and bone mineralization.

Pharmacodynamics

Dipotassium phosphate affects the body by replenishing potassium levels, which can be depleted in conditions causing hypokalemia. The phosphate component supports various biochemical processes, including ATP synthesis and cellular metabolism. The balance of electrolytes is crucial for normal physiological function, and dipotassium phosphate helps maintain this balance.

Pharmacokinetics

Dipotassium phosphate is rapidly absorbed in the gastrointestinal tract after oral administration. The potassium is distributed to various tissues, and excess is excreted primarily through the kidneys. The phosphate component is also regulated by renal excretion. The biological half-life of potassium varies depending on the individual's renal function and overall health.

Pregnancy

Consult relevant guidelines, as data on safety in pregnancy may be limited.

Breast-feeding

Consult relevant guidelines, as data on safety during breastfeeding may be limited.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Wound healing
• Skin ulceration
• Burns
• Psoriasis
• Dermatitis

Dosage

Children: Refer to the BNF for Children for appropriate dosing information based on the child's age and condition.

Adults: Refer to the BNF for specific formulations and dosing guidelines, as dosages may vary based on the condition being treated and the formulation used.

Mechanism of action

While there is no well-controlled data to formally substantiate the method of action, ongoing studies suggest that allantoin may induce a histological wound healing profile in animal models, leading to improved reestablishment of normal skin. This includes increased vasodilation, inflammatory cell presence, angiogenesis, fibroblast proliferation, and collagen deposition in treated wounds compared to untreated ones.

Pharmacodynamics

There is limited controlled data regarding the pharmacodynamic properties of allantoin. However, studies indicate that allantoin may possess moisturizing and keratolytic effects, increasing the extracellular matrix's water content and enhancing the desquamation of dead skin cells. These activities can promote cell proliferation and facilitate wound healing.

Pharmacokinetics

Specific pharmacokinetic data for allantoin in humans is limited. However, it is known to be applied topically, which suggests local absorption at the site of application. Systemic absorption is considered minimal due to its low molecular weight and hydrophilicity.

Pregnancy

There is limited data on the safety of allantoin in pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Allantoin is generally considered safe during breastfeeding, but caution is recommended. Consult a healthcare professional before use.

Storage

Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.

Formulations

• Topical cream
• Gel
• Ointment

Dosage

Children: Refer to specific guidelines for pediatric dosing; consult the BNF for Children for accurate dosage information.

Adults: Refer to specific guidelines for use; dosage may vary based on the context of use.

Mechanism of action

Hydroxide ions act primarily as bases, neutralizing acids to form water and salts. They participate in various biochemical pathways, including selenium metabolism and the degradation of reactive oxygen species. Hydroxide can influence enzyme activity and stability by altering the pH of the environment, thereby affecting metabolic reactions.

Pharmacodynamics

Hydroxide ions can impact biological processes by changing the local pH, which influences enzyme activity, ion transport, and the solubility of other compounds. Their ability to neutralize acids can help regulate physiological pH, contributing to homeostasis in living organisms.

Pharmacokinetics

As an inorganic ion, hydroxide does not undergo traditional pharmacokinetic processes like absorption, distribution, metabolism, or excretion. Instead, it is rapidly equilibrated in biological fluids and participates in acid-base reactions, having immediate effects on the local environment.

Pregnancy

There is limited information regarding the use of hydroxide during pregnancy. Consult a healthcare professional for advice.

Breast-feeding

Limited data is available on the excretion of hydroxide in breast milk. Consult a healthcare professional before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Cancer (various types)
• Rheumatoid arthritis
• Multiple sclerosis
• Inflammatory bowel disease
• Psoriasis
• Hypercholesterolemia
• Infectious diseases (e.g., COVID-19)

Dosage

Children: Refer to the BNF for Children for paediatric dosing information, as it varies based on the specific monoclonal antibody and the condition being treated.

Adults: Refer to the specific monoclonal antibody product information for adult dosage, as it varies based on indication and specific agent used.

Mechanism of action

Monoclonal antibodies work by binding to specific proteins on the surface of cells. This binding can block the activity of certain proteins, mark cells for destruction by the immune system, or deliver cytotoxic agents directly to target cells. The mechanism of action varies depending on the specific monoclonal antibody but often involves modulation of immune response, inhibition of cell proliferation, and induction of apoptotic pathways.

Pharmacodynamics

The pharmacodynamics of monoclonal antibodies is primarily characterized by their specificity and affinity for targeted antigens. This leads to a variety of effects, including neutralization of pathogens, blockade of receptor-ligand interactions, and antibody-dependent cellular cytotoxicity. The clinical effects depend on the disease being treated and the specific antibody's action, such as inducing tumor regression in cancer or reducing inflammation in autoimmune diseases.

Pharmacokinetics

Monoclonal antibodies typically have a long half-life, allowing for less frequent dosing. They are generally administered intravenously or subcutaneously, with absorption and distribution influenced by the antibody's size and charge. The elimination occurs primarily through proteolytic degradation and intracellular recycling. Factors such as patient-specific variables, including immunogenicity and the presence of antibodies against the monoclonal antibody, can impact pharmacokinetics.

Interactions

• abatacept+monoclonalantibodies: Severe (increases risk of generalised infection (possibly life-threatening))
• anakinra+monoclonalantibodies: Severe (increases risk of generalised infection (possibly life-threatening))
• anthracyclines+monoclonalantibodies: Severe (increases risk of cardiotoxicity)
• filgotinib+monoclonalantibodies: Severe (increases risk of immunosuppression)
• monoclonalantibodies+fingolimod: Severe (increases risk of generalised infection (possibly life-threatening))
• normal immunoglobulin+monoclonalantibodies: Severe (affects effects)
• monoclonalantibodies+ozanimod: Severe (increases risk of generalised infection (possibly life-threatening))
• monoclonalantibodies+siponimod: Severe (increases risk of generalised infection (possibly life-threatening))
• monoclonalantibodies+vemurafenib: Severe (increases risk of hepatotoxicity)
• monoclonalantibodies+aminophylline: Moderate (decreases exposure)

Indications

• Hypokalemia
• Electrolyte replacement
• Management of certain cardiac conditions
• Hypertension management
• Support in renal function

Dosage

Children: Refer to BNF for Children for appropriate dosing recommendations for pediatric patients.

Adults: Refer to BNF for specific dosing guidance based on clinical condition and formulation.

Mechanism of action

Potassium ions serve as the primary intracellular cation, establishing a transmembrane gradient that is essential for nerve conduction and muscle activity. The sodium-potassium ATPase transporter maintains this gradient, influencing the movement of sodium and potassium across cell membranes. Potassium also contributes to vasodilation and the reduction of sodium reabsorption, leading to lower blood pressure and improved renal function.

Pharmacodynamics

Potassium is critical for maintaining electrolyte balance, influencing nerve transmission, muscle contraction, and fluid balance. Increased dietary potassium is associated with lower blood pressure and may reduce the risk of stroke and heart disease. Furthermore, potassium intake may have protective effects against bone loss in the elderly and the formation of kidney stones. However, solid oral potassium preparations can lead to gastrointestinal lesions, necessitating the use of diluted or injectable forms in patients with gastrointestinal concerns.

Pharmacokinetics

Potassium is predominantly stored intracellularly, with a concentration approximately 30 times higher in cells than in extracellular fluid. The body regulates potassium levels through renal excretion and dietary intake. In healthy individuals, significant deviations in potassium levels are uncommon, but conditions such as vomiting, diarrhea, and renal disease can affect potassium balance and necessitate careful monitoring.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Muscle weakness
• Palpitations
• Arrhythmias

Interactions

• Potassium-sparing diuretics may enhance potassium levels
• ACE inhibitors may increase serum potassium levels
• Non-steroidal anti-inflammatory drugs (NSAIDs) may reduce renal potassium excretion

Precautions

• Monitor renal function regularly
• Use with caution in patients with renal impairment
• Consider potential gastrointestinal lesions with solid oral preparations

Pregnancy

Potassium is generally considered safe in pregnancy when used as directed, but monitoring of levels is recommended.

Breast-feeding

Potassium is excreted in breast milk, but normal dietary intake is not expected to harm the nursing infant.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Oral tablets
• Oral solution
• Injectable solution

Indications

• Disinfection of medical instruments
• Sterilization of endoscopes
• General surface disinfection in healthcare settings

Dosage

Children: Refer to specific product guidelines for concentration and exposure time.

Adults: Refer to specific product guidelines for concentration and exposure time.

Mechanism of action

Orthophthalaldehyde acts as a potent biocide by forming cross-links with amino groups in proteins, leading to the denaturation and inactivation of microbial cells. This process disrupts vital cellular functions, ultimately resulting in cell death. The compound's effectiveness is attributed to its ability to penetrate microbial cell walls and interact with cellular components.

Pharmacodynamics

Orthophthalaldehyde exhibits broad-spectrum antimicrobial activity, making it effective against a wide variety of pathogens. The compound is particularly noted for its rapid action, with significant microbial inactivation occurring within a short exposure time. Its efficacy is influenced by factors such as concentration, temperature, and contact time.

Pharmacokinetics

The pharmacokinetic profile of orthophthalaldehyde is not well-characterized, as it is primarily used in external applications for disinfection rather than systemic administration. Its stability and potency as a disinfectant are maintained under various conditions, but specific absorption, distribution, metabolism, and excretion data are limited.

Pregnancy

There is limited information regarding the safety of orthophthalaldehyde in pregnancy. It is advisable to avoid use unless clearly needed and the benefits outweigh the risks.

Breast-feeding

There is no available data on the excretion of orthophthalaldehyde in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store in a cool, dry place away from light. Ensure containers are tightly closed when not in use.

Indications

• Hypophosphatemia
• Calcium phosphate deficiency
• Nutritional supplementation
• pH adjustment in pharmaceutical formulations

Dosage

Children: Refer to BNF for Children for specific dosing recommendations based on indication.

Adults: Refer to clinical guidelines or BNF for specific dosing recommendations based on indication.

Mechanism of action

Phosphoric acid provides phosphate ions that are critical for numerous biochemical reactions in the body. These phosphate ions are involved in the formation of ATP, which is essential for energy transfer within cells. The acid itself dissociates in aqueous solutions, releasing hydrogen ions and contributing to pH levels, which can affect enzymatic activities and cellular functions.

Pharmacodynamics

Phosphoric acid acts by replenishing phosphate levels in the body, which can be important in various physiological processes including energy metabolism, bone mineralization, and the synthesis of nucleic acids. Its effects on pH regulation can also influence metabolic pathways, particularly in managing acidosis or alkalosis.

Pharmacokinetics

Phosphoric acid is generally administered orally or intravenously, depending on the therapeutic application. Following administration, it is absorbed in the gastrointestinal tract, with phosphate ions distributed throughout the body. The kidneys play a significant role in regulating phosphate homeostasis, with excess phosphate being excreted in urine. The half-life of phosphoric acid is not well defined, as it is rapidly metabolized and utilized in various metabolic pathways.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Hypophosphatemia

Precautions

• Use with caution in patients with renal impairment
• Monitor phosphate levels in patients receiving long-term therapy
• Consider potential for gastrointestinal irritation

Pregnancy

Phosphoric acid is generally considered safe in pregnancy when used in recommended doses, but caution is advised.

Breast-feeding

Phosphoric acid is excreted in breast milk, use with caution and under medical supervision.

Storage

Store at room temperature, away from moisture and heat.

Formulations

• Oral solutions
• Tablets
• Syrups

Indications

• Lead poisoning
• Mercury poisoning
• Hypercalcemia
• Hyperphosphatemia
• Diagnostic procedures

Dosage

Children: Refer to BNF for Children for appropriate dosing guidelines based on specific indication and patient condition.

Adults: Refer to BNF for appropriate dosing guidelines based on specific indication and patient condition.

Mechanism of action

Versenol acts as a chelating agent that forms stable complexes with divalent and trivalent metal ions, such as lead, mercury, and calcium. The chelation process reduces the free metal ion concentration in the bloodstream, facilitating the excretion of the metal ions through the kidneys. This action helps to mitigate the toxic effects of heavy metals on biological systems.

Pharmacodynamics

The binding of Versenol to metal ions alters the pharmacokinetics of these metals, decreasing their availability and toxicity. By promoting the renal excretion of the metal-chelate complexes, Versenol helps to restore normal physiological function and reduce the risk of organ damage due to heavy metal accumulation.

Pharmacokinetics

Versenol is administered intravenously or intramuscularly, and its absorption and distribution are influenced by the route of administration. Once in the bloodstream, it rapidly binds to metal ions. The elimination half-life of Versenol is relatively short, with renal excretion being the primary route of elimination. The drug is not metabolized significantly and is excreted unchanged in the urine.

Pregnancy

There is limited information on the safety of Versenol in pregnancy. It should only be used if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known if Versenol is excreted in human breast milk. Caution should be exercised when administering to a nursing mother.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Mechanism of action

There is no well controlled data that can formally substantiate the method of action. However, ongoing studies suggest that there may exist a histological wound healing profile induced by allantoin in rats that leads to the amelioration and fastening of the reestablishment of normal skin. This facilitation of wound healing is supported by observations that wounds inflicted to rat subjects to which topical allantoin preparations were applied histologically demonstrated increased vasodilation, presence of inflammatory exudates, number of inflammatory cells, angiogenesis, fibroblast proliferation, and increased collagen deposition when compared to rat subjects with wounds that did not receive any allantoin administration.

Pharmacodynamics

There is no well controlled and appropriate data that can formally substantiate the pharmacodynamic properties of allantoin. Nevertheless, ongoing studies suggest that allantoin possesses moisturizing and keratolytic effects, as well as abilities to increase the water content of the extracellular matrix and enhance the desquamation of upper layers of dead skin cells, all of which are activities that can promote cell proliferation and facilitate wound healing.

Mechanism of action

Potassium ion is the primary intracellular cation found in virtually all body tissues. The total amount of body potassium in adults is estimated at 45 millimole (mmol)/kg body weight (about 140 g for an adult weighing 175 pounds; 1 mmol = 1 milliequivalent or 39.1 mg of potassium). Potassium mainly stays in cells, and a small amount can be found in the extracellular fluid. The amount of potassium that stays in the cell (intracellular) is 30 times that of extracellular concentration, creating a transmembrane gradient, regulated by the sodium-potassium (Na+/K+) ATPase transporter. This is an important gradient for nerve conduction, muscle contractions, and renal function. Vomiting, diarrhea, renal disease, medications, and other conditions that alter potassium excretion or shift it inside or outside of cells. In healthy patients individuals with normal renal function, markedly high or low potassium levels are rare. **Effect on blood pressure** Potassium decreases reduces intravascular volume, by reducing sodium reabsorption through an increase in urinary sodium excretion. This short-term effect, however, does not explain the long-term effects of potassium on blood pressure. Increased plasma potassium levels that occur through intake are associated with vasodilation occurring via stimulation of the sodium-potassium adenosine triphosphatase pump (Na+/-K+ATPase) and opening of potassium channels of the sodium-potassium adenosine triphosphatase pump. Other possible mechanisms of action for potassium may include alterations in barroreflex sensitivity and hormone sensitivity in vascular smooth muscle and cells of the sympathetic nervous system. **Effect on electrolyte balance and body systems** The potassium gradient across the membrane of a cell regulates cell membrane potential, maintained predominantly by the sodium-potassium (Na+/-K+ ATPase pump). Transmembrane electro-chemical gradients encourage diffusion of Na+ extracellularly and K+ intracellularly. Potassium supplementation prevents hypokalemia to maintain this balance and is often used in an oral solution or injection form in the clinical setting, preventing harmful effects such as arrhythmias, abnormal muscle function, and neurological disturbances. When activated, the Na+/-K+ ATPase pump exchanges two extracellular K+ ions for three intracellular sodium (Na+) ions, impacting membrane potential via either excitation or inhibition. This is especially important in the homeostasis of the nervous system, kidney, and cardiac muscle tissue. The body and cell distributions of potassium in normal conditions are known as internal and external balance, respectively. Reduced serum potassium (or imbalance) increases the risk of ventricular arrhythmia, heart failure and left ventricular hypertrophy (LVH).

Pharmacodynamics

Potassium maintains an electrolyte gradient on cell surfaces, keeping at specific concentrations inside and outside of the cell; this impacts fluid and electrolyte balance, nerve transmission, muscle contraction, as well as cardiac and kidney function. Clinical evidence has associated potassium intake with lower blood pressure in adults, reducing the risk stroke and heart disease. Dietary potassium may exert beneficial effects on bone loss in the elderly and kidney stones. Consumption of white vegetables, which are normally high in potassium, is associated with a lower risk of stroke. **A note on gastrointestinal lesions** Potassium in solid oral preparations (for example, tablets) can cause ulcerative or stenotic lesions in the esophagus and stomach. Use diluted liquid potassium preparations or injection preparations if there are concerns about gastrointestinal health.